Female 61 years old Reason: r/o pancreatic cancer, pt is a carrier of BRCA-2 mutation History: newly diagnosed pre-diabetic, dilated CBD per outside U/S ABDOMEN:LIVER, BILIARY TRACT: Liver is normal in morphology. Within segment 6 of the liver there is a T2 hyperintense lesion that shows peripheral nodular enhancement and progressive central enhancement compatible with a hemangioma. No suspicious hepatic lesions. Hepatic and portal veins are patent.Patient is status post cholecystectomy. The common bile duct diameter increased since the CT dated 2/17/2014. The common bile duct at its proximal aspect measures 17 mm and measures 7 mm at the head of the pancreas. Its most distal portion in the ampulla is suboptimally imaged by MR.SPLEEN: No significant abnormality noted.PANCREAS: Pancreas is normal in morphology and signal. Pancreatic duct is mildly dilated measuring up to 3 mm. No discrete pancreatic mass is evident.ADRENAL GLANDS: No significant abnormality noted.KIDNEYS, URETERS: No significant abnormality noted.RETROPERITONEUM, LYMPH NODES: No retroperitoneal lymphadenopathy.BOWEL, MESENTERY: No significant abnormality noted.BONES, SOFT TISSUES: No significant abnormality noted.OTHER: No significant abnormality noted.
1.Interval increase in the diameter of the common bile duct without a definite mass but the transitions point is about the level of the ampulla. Mild pancreatic duct dilatation without an evident pancreatic mass. This may be due to either a small mass (below imaging threshold) or benign ampullary stenosis. Further evaluation of the ampulla with EUS can be performed as clinically indicated.2.Right hepatic lobe hemangioma.